Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
Total Valuation
NeuroPace has a market cap or net worth of $472.35M. The enterprise value is $516.45M.
Market Cap$472.35M
Enterprise Value$516.45M
Share Statistics
NeuroPace has 33,666,946 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,666,946
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NeuroPace’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -18.18%.
Return on Equity (ROE)-1.13
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-18.18%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee543.40K
Profits Per Employee-116.66K
Employee Count184
Asset Turnover0.95
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of NeuroPace is ―. NeuroPace’s PEG ratio is 0.81.
PE Ratio―
PS Ratio5.05
PB Ratio26.55
Price to Fair Value26.55
Price to FCF-44.56
Price to Operating Cash Flow-41.71
PEG Ratio0.81
Income Statement
In the last 12 months, NeuroPace had revenue of 99.99M and earned -21.46M in profits. Earnings per share was -0.66.
Revenue99.99M
Gross Profit77.22M
Operating Income-16.34M
Pretax Income-21.46M
Net Income-21.46M
EBITDA-14.39M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was -11.01M and capital expenditures -332.00K, giving a free cash flow of -11.34M billion.
Operating Cash Flow-11.01M
Free Cash Flow-11.34M
Free Cash Flow per Share-0.34
Dividends & Yields
NeuroPace pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change39.74%
50-Day Moving Average15.57
200-Day Moving Average12.50
Relative Strength Index (RSI)41.03
Average Volume (3m)165.68K
Important Dates
NeuroPace upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateMar 3, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
NeuroPace as a current ratio of 5.28, with Debt / Equity ratio of 372.22%
Current Ratio5.28
Quick Ratio4.33
Debt to Market Cap0.14
Net Debt to EBITDA-3.42
Interest Coverage Ratio-2.19
Taxes
In the past 12 months, NeuroPace has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroPace EV to EBITDA ratio is -38.53, with an EV/FCF ratio of -48.90.
EV to Sales5.54
EV to EBITDA-38.53
EV to Free Cash Flow-48.90
EV to Operating Cash Flow-50.37
Balance Sheet
NeuroPace has $61.06M in cash and marketable securities with $70.84M in debt, giving a net cash position of -$9.78M billion.
Cash & Marketable Securities$61.06M
Total Debt$70.84M
Net Cash-$9.78M
Net Cash Per Share-$0.29
Tangible Book Value Per Share$0.58
Margins
Gross margin is 77.23%, with operating margin of -16.34%, and net profit margin of -21.47%.
Gross Margin77.23%
Operating Margin-16.34%
Pretax Margin-21.47%
Net Profit Margin-21.47%
EBITDA Margin-14.39%
EBIT Margin-16.34%
Analyst Forecast
The average price target for NeuroPace is $20.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$20.00
Price Target Upside37.36% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast24.08%
EPS Growth Forecast24.08%